Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma, Kaposi 3Myeloproliferative Disorders 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Acquired Immunodeficiency Syndrome 2Plasmablastic Lymphoma 1Optic Nerve Glioma 1Neurofibromatosis 1 1Myelodysplastic Syndromes 1Multi-centric Castleman's Disease 1Lymphoma, Primary Effusion 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Chronic 1Epstein-Barr Virus Infections 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Zidovudine 12Doxorubicin 11Vincristine 9Bleomycin 8Interferon alpha-2 6Methotrexate 5Leucovorin 5Dexamethasone 5Cyclophosphamide 5sargramostim 4Filgrastim 4Cytarabine 4Etoposide 3pomalidomide 2interferon alfa-n1 2Thalidomide 2Rituximab 2Isotretinoin 2Interleukin-2 2Didanosine 2Allopurinol 2tocilizumab 1plerixafor 1liposomal doxorubicin 1interferon gamma-1b 1abemaciclib 1Zalcitabine 1Vinblastine 1Valganciclovir 1Tumor Necrosis Factor-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Acquired Immunodeficiency Syndrome × pomalidomide × Clear all
NCT02659930 2026-06-04

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 1 Active not recruiting
62 enrolled
Sarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT04902443 2026-06-04

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
58 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡